Alpine Immune Sciences, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $4.5 Billion | 1/12 | ALPN $4.5B |
MLTX $2.7B |
DAWN $1.2B |
BCYC $866.2M |
ANAB $645.7M |
STOK $565.7M |
GLUE $416.5M |
TERN $344.9M |
TNYA $95.1M |
ABOS $87.1M |
IGMS $85.0M |
ANEB $54.6M |
Gross Margin | 98% | 3/12 | IGMS 100% |
GLUE 100% |
ALPN 98% |
ANAB 98% |
DAWN 92% |
STOK 77% |
BCYC 18% |
TERN 0% |
TNYA 0% |
ABOS 0% |
ANEB 0% |
MLTX 0% |
Profit Margin | -100% | 7/12 | DAWN 100% |
TERN 0% |
TNYA 0% |
ABOS 0% |
ANEB 0% |
MLTX 0% |
ALPN -100% |
ANAB -100% |
BCYC -100% |
STOK -100% |
IGMS -100% |
GLUE -100% |
EBITDA margin | -321% | 9/12 | DAWN 148% |
ANAB -76% |
TERN -100% |
TNYA -100% |
ABOS -100% |
ANEB -100% |
MLTX -100% |
GLUE -288% |
ALPN -321% |
STOK -517% |
BCYC -2386% |
IGMS -12031% |
Quarterly Revenue | $7.0 Million | 4/12 | ANAB $30.0M |
DAWN $20.1M |
GLUE $9.2M |
ALPN $7.0M |
STOK $4.9M |
BCYC $2.7M |
IGMS $516,000 |
TERN $0 |
TNYA $0 |
ABOS $0 |
ANEB $0 |
MLTX $0 |
Quarterly Earnings | -$17.9 Million | 3/12 | DAWN $37.0M |
ANEB -$2.2M |
ALPN -$17.9M |
TERN -$21.9M |
GLUE -$23.9M |
TNYA -$25.6M |
STOK -$26.4M |
ABOS -$29.8M |
ANAB -$32.9M |
MLTX -$35.9M |
BCYC -$50.8M |
IGMS -$61.4M |
Quarterly Free Cash Flow | -$27.7 Million | 10/12 | ANEB -$1.7M |
DAWN -$5.0M |
ANAB -$10.1M |
TERN -$16.5M |
TNYA -$20.0M |
GLUE -$21.4M |
STOK -$21.7M |
ABOS -$24.6M |
MLTX -$25.4M |
ALPN -$27.7M |
IGMS -$39.7M |
BCYC -$40.2M |
Trailing 4 Quarters Revenue | $56.5 Million | 2/12 | ANAB $57.2M |
ALPN $56.5M |
BCYC $36.9M |
DAWN $28.8M |
STOK $16.7M |
GLUE $15.0M |
IGMS $2.9M |
MLTX $19,738 |
TERN $0 |
TNYA $0 |
ABOS $0 |
ANEB $0 |
Trailing 4 Quarters Earnings | -$36.8 Million | 2/12 | ANAB $30.0M |
DAWN $20.1M |
GLUE $9.2M |
ALPN $7.0M |
STOK $4.9M |
BCYC $2.7M |
IGMS $516,000 |
TERN -$0 |
TNYA -$0 |
ABOS -$0 |
ANEB -$0 |
MLTX -$0 |
Quarterly Earnings Growth | -63% | 10/12 | DAWN 180% |
GLUE 32% |
TERN 26% |
ANAB 12% |
TNYA 12% |
ANEB 11% |
IGMS 1% |
BCYC -2% |
STOK -8% |
ALPN -63% |
ABOS -130% |
MLTX -281% |
Annual Earnings Growth | 46% | 2/12 | DAWN 50% |
ALPN 46% |
ANEB 21% |
GLUE 15% |
IGMS 14% |
STOK 9% |
TNYA 9% |
BCYC 6% |
ANAB -6% |
TERN -6% |
ABOS -71% |
MLTX -110161% |
Quarterly Revenue Growth | -25% | 11/12 | ANAB 805% |
STOK 48% |
IGMS 1% |
GLUE 0% |
TERN 0% |
DAWN 0% |
TNYA 0% |
ABOS 0% |
ANEB 0% |
MLTX 0% |
ALPN -25% |
BCYC -50% |
Annual Revenue Growth | 219% | 3/12 | STOK 505% |
ANAB 317% |
ALPN 219% |
IGMS 57% |
GLUE 0% |
TERN 0% |
DAWN 0% |
TNYA 0% |
ABOS 0% |
ANEB 0% |
MLTX 0% |
BCYC -7% |
Cash On Hand | $33.0 Million | 10/12 | BCYC $890.9M |
DAWN $422.8M |
MLTX $375.7M |
TERN $270.1M |
ANAB $191.6M |
STOK $150.0M |
GLUE $125.6M |
IGMS $42.9M |
ABOS $33.2M |
ALPN $33.0M |
TNYA $8.2M |
ANEB $1.4M |
Short Term Debt | $950,000 | 8/12 | IGMS $6.7M |
BCYC $5.6M |
GLUE $3.6M |
TNYA $3.0M |
STOK $2.3M |
ANAB $1.9M |
MLTX $1.4M |
ALPN $950,000 |
TERN $272,000 |
ABOS $129,000 |
DAWN $77,000 |
ANEB -$0 |
Long Term Debt | $8.7 Million | 6/12 | IGMS $78.3M |
GLUE $40.1M |
ABOS $29.9M |
ANAB $14.6M |
TNYA $11.5M |
ALPN $8.7M |
BCYC $5.5M |
STOK $3.0M |
DAWN $2.5M |
MLTX $1.9M |
TERN $1.0M |
ANEB $0 |
PE | -1.00 | 1/12 | ALPN -1.00 |
ANAB -1.00 |
BCYC -1.00 |
STOK -1.00 |
IGMS -1.00 |
GLUE -1.00 |
TERN -1.00 |
DAWN -1.00 |
TNYA -1.00 |
ABOS -1.00 |
ANEB -1.00 |
MLTX -1.00 |
PS | 78.85 | 2/12 | MLTX 138058.12 |
ALPN 78.85 |
DAWN 42.90 |
STOK 33.79 |
IGMS 29.14 |
GLUE 27.82 |
BCYC 23.48 |
ANAB 11.29 |
TERN -1.00 |
TNYA -1.00 |
ABOS -1.00 |
ANEB -1.00 |
PB | 13.40 | 2/12 | ANEB 28.78 |
ALPN 13.40 |
ANAB 7.65 |
MLTX 5.50 |
STOK 2.44 |
DAWN 2.23 |
GLUE 2.03 |
IGMS 1.08 |
BCYC 1.04 |
TERN 0.95 |
TNYA 0.84 |
ABOS 0.40 |
PC | 134.99 | 1/12 | ALPN 134.99 |
ANEB 38.91 |
TNYA 11.55 |
MLTX 7.25 |
STOK 3.77 |
ANAB 3.37 |
GLUE 3.32 |
DAWN 2.92 |
ABOS 2.63 |
IGMS 1.98 |
TERN 1.28 |
BCYC 0.97 |
Liabilities to Equity | 0.12 | 9/12 | ANAB 4.85 |
IGMS 2.86 |
GLUE 0.53 |
ANEB 0.30 |
STOK 0.26 |
TNYA 0.25 |
ABOS 0.23 |
BCYC 0.20 |
ALPN 0.12 |
DAWN 0.08 |
MLTX 0.05 |
TERN 0.04 |
ROA | -0.10 | 1/12 | ALPN -10% | DAWN -15% | BCYC -17% | TERN -23% | ABOS -31% | ANAB -34% | STOK -36% | GLUE -38% | IGMS -72% | TNYA -83% | ANEB -321% | MLTX -8478% |
ROE | -0.11 | 1/12 | ALPN -11% |
DAWN -16% |
BCYC -20% |
TERN -24% |
ABOS -38% |
STOK -45% |
GLUE -58% |
TNYA -104% |
ANAB -196% |
IGMS -278% |
ANEB -417% |
MLTX -8999% |
Current Ratio | 9.13 | 4/12 | TERN 27.48 |
MLTX 22.82 |
DAWN 13.25 |
ALPN 9.13 |
BCYC 6.01 |
ABOS 5.36 |
TNYA 5.02 |
STOK 4.79 |
ANEB 4.34 |
GLUE 2.87 |
IGMS 1.35 |
ANAB 1.21 |
Quick Ratio | 7.47 | 4/12 | ALPN -1.00 |
ANAB -1.00 |
BCYC -1.00 |
STOK -1.00 |
IGMS -1.00 |
GLUE -1.00 |
TERN -1.00 |
DAWN -1.00 |
TNYA -1.00 |
ABOS -1.00 |
ANEB -1.00 |
MLTX -1.00 |
Long Term Debt to Equity | 0.03 | 6/12 | IGMS} 0.99 |
GLUE} 0.19 |
ANAB} 0.17 |
ABOS} 0.14 |
TNYA} 0.10 |
ALPN} 0.03 |
BCYC} 0.01 |
STOK} 0.01 |
TERN} 0.00 |
DAWN} 0.00 |
ANEB} 0.00 |
MLTX} 0.00 |
Debt to Equity | 0.03 | 6/12 | IGMS 0.58 |
GLUE 0.21 |
ANAB 0.20 |
ABOS 0.14 |
TNYA 0.13 |
ALPN 0.03 |
BCYC 0.01 |
STOK 0.01 |
MLTX 0.01 |
TERN 0.00 |
DAWN 0.00 |
ANEB 0.00 |
Burn Rate | 1.78 | 7/12 | BCYC 17.00 |
TERN 12.25 |
MLTX 10.33 |
ANAB 5.65 |
STOK 5.53 |
GLUE 4.76 |
ALPN 1.78 |
ABOS 1.07 |
IGMS 0.65 |
ANEB 0.64 |
TNYA 0.31 |
DAWN -11.45 |
Cash to Cap | 0.01 | 12/12 | BCYC 1.03 |
TERN 0.78 |
IGMS 0.50 |
ABOS 0.38 |
DAWN 0.34 |
ANAB 0.30 |
GLUE 0.30 |
STOK 0.27 |
MLTX 0.14 |
TNYA 0.09 |
ANEB 0.03 |
ALPN 0.01 |
CCR | 1.55 | 1/12 | ALPN 1.55 |
GLUE 0.90 |
ABOS 0.83 |
STOK 0.82 |
BCYC 0.79 |
TNYA 0.78 |
ANEB 0.77 |
TERN 0.75 |
MLTX 0.71 |
IGMS 0.65 |
ANAB 0.31 |
DAWN -0.13 |
EV to EBITDA | -196.61 | 12/12 | DAWN} 27.54 |
BCYC} 0.30 |
TERN} -1.00 |
TNYA} -1.00 |
ABOS} -1.00 |
ANEB} -1.00 |
IGMS} -1.42 |
GLUE} -12.62 |
STOK} -16.51 |
ANAB} -20.68 |
MLTX} -65.31 |
ALPN} -196.61 |
EV to Revenue | 78.44 | 2/12 | MLTX 119197.26 |
ALPN 78.44 |
IGMS 30.16 |
DAWN 28.32 |
STOK 24.96 |
GLUE 22.35 |
ANAB 8.23 |
BCYC -0.52 |
TERN -1.00 |
TNYA -1.00 |
ABOS -1.00 |
ANEB -1.00 |